Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Bristol-Myers Squibb
Trishula Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Incyte Corporation
Gilead Sciences
University of Miami
Eli Lilly and Company